{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:59:31Z","timestamp":1770325171841,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council, UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.neuroimage.2009.12.058","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T09:10:32Z","timestamp":1261645832000},"page":"524-531","source":"Crossref","is-referenced-by-count":102,"title":["The test\u2013retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function"],"prefix":"10.1016","volume":"50","author":[{"given":"Alice","family":"Egerton","sequence":"first","affiliation":[]},{"given":"Arsime","family":"Demjaha","sequence":"additional","affiliation":[]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[]},{"given":"Mitul A.","family":"Mehta","sequence":"additional","affiliation":[]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.neuroimage.2009.12.058_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.schres.2008.09.011","article-title":"Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging","volume":"106","author":"Bose","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-4159.1982.tb12555.x","article-title":"Characteristics of dihydroxyphenylalanine\/5-hydroxytryptophan decarboxylase activity in brain and liver of cat","volume":"37","author":"Bouchard","year":"1981","journal-title":"J. Neurochem."},{"issue":"Suppl. 3","key":"10.1016\/j.neuroimage.2009.12.058_bib3","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/ana.10480","article-title":"Imaging end points for monitoring neuroprotection in Parkinson's disease","volume":"53","author":"Brooks","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2003.tb07460.x","article-title":"PET studies on the function of dopamine in health and Parkinson's disease","volume":"991","author":"Brooks","year":"2003","journal-title":"Ann. N. Y. Acad. Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.neuroimage.2009.12.058_bib5","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.expneurol.2003.08.008","article-title":"Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease","volume":"184","author":"Brooks","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.biopsych.2005.12.017","article-title":"Imaging in Parkinson's disease: the role of monoamines in behavior","volume":"59","author":"Brooks","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)02124-3","article-title":"Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus","volume":"311","author":"Bruck","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neuroimage.2008.12.035","article-title":"Measuring fMRI reliability with the intra-class correlation coefficient","volume":"45","author":"Caceres","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pscychresns.2007.11.003","article-title":"Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA","volume":"163","author":"Cropley","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/jcbfm.1993.85","article-title":"Pharmacokinetics of plasma 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans","volume":"13","author":"Cumming","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.1997.tb48637.x","article-title":"On the rate of decarboxylation of dopa to dopamine in the living mammillian brain","volume":"835","author":"Cumming","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/syn.1071","article-title":"Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo","volume":"41","author":"Danielsen","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","article-title":"Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls","volume":"36","author":"Eshuis","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300103","article-title":"Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo","volume":"28","author":"Grunder","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mds.870080308","article-title":"Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa","volume":"8","author":"Guttman","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hbm.10123","article-title":"Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe","volume":"19","author":"Hammers","year":"2003","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01250373","article-title":"Brain kinetics of l-[beta-11C]dopa in humans studied by positron emission tomography","volume":"86","author":"Hartvig","year":"1991","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1351-5101.2003.00709.x","article-title":"The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease","volume":"11","author":"Heiss","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00006231-200312000-00002","article-title":"Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride","volume":"24","author":"Hirvonen","year":"2003","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib22","first-page":"1472","article-title":"The effects of carbidopa administration on 6-[18F]fluoro-l-dopa kinetics in positron emission tomography","volume":"33","author":"Hoffman","year":"1992","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jcbfm.1993.8","article-title":"6-[18F]fluoro-l-dopa metabolism in living human brain: a comparison of six analytical methods","volume":"13","author":"Hoshi","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib24","doi-asserted-by":"crossref","first-page":"s13","DOI":"10.1192\/bjp.191.51.s13","article-title":"Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis","volume":"51","author":"Howes","year":"2007","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","article-title":"Elevated striatal dopamine function linked to prodromal signs of schizophrenia","volume":"66","author":"Howes","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","article-title":"Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls","volume":"50","author":"Jokinen","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib27","article-title":"Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study","author":"Kumakura","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tips.2005.03.007","article-title":"A renaissance in trace amines inspired by a novel GPCR family","volume":"26","author":"Lindemann","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004647-200303000-00004","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum","volume":"23","author":"Martinez","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00004647-200109000-00002","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum","volume":"21","author":"Mawlawi","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archpsyc.61.2.134","article-title":"Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study","volume":"61","author":"McGowan","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients","volume":"1","author":"McGraw","year":"1996","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib33","first-page":"1936","article-title":"Correction of head movement on PET studies: comparison of methods","volume":"47","author":"Montgomery","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(03)02721-5","article-title":"Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study","volume":"982","author":"Moore","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","article-title":"Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study","volume":"29","author":"Moore","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.1075","article-title":"Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease","volume":"50","author":"Nakamura","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2008.11.006","article-title":"Regional dopamine synthesis in patients with schizophrenia using l-[beta-11C]DOPA PET","volume":"108","author":"Nozaki","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.lfs.2006.02.017","article-title":"Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with l-[beta-11C]DOPA","volume":"79","author":"Ota","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations","volume":"5","author":"Patlak","year":"1985","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib41","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awh649","article-title":"Factors affecting the clinical outcome after neural transplantation in Parkinson's disease","volume":"128","author":"Piccini","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib42","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.44.7.1292","article-title":"The effect of entacapone (OR-611) on brain [18F]-6-l-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease","volume":"44","author":"Sawle","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ana.410340304","article-title":"Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels","volume":"34","author":"Snow","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1361-8415(96)80011-9","article-title":"Automated 3-D registration of MR and CT images of the head","volume":"1","author":"Studholme","year":"1996","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5","article-title":"Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity","volume":"28","author":"Tedroff","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0028-3908(98)00085-9","article-title":"Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone","volume":"37","author":"Torstenson","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00004647-199911000-00003","article-title":"Multiresolution analysis of emission tomography images in the wavelet domain","volume":"19","author":"Turkheimer","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hbm.20325","article-title":"'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-l-DOPA-PET investigation","volume":"28","author":"Vernaleken","year":"2007","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib50","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuroimage.2005.11.014","article-title":"Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge","volume":"30","author":"Vernaleken","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib51","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.neuroimage.2007.12.045","article-title":"Baseline [(18)F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects","volume":"40","author":"Vernaleken","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroimage.2009.12.058_bib52","first-page":"18","article-title":"Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects","volume":"35","author":"Vingerhoets","year":"1994","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib53","first-page":"421","article-title":"Reproducibility and discriminating ability of fluorine-18-6-fluoro-l-DOPA PET in Parkinson's disease","volume":"37","author":"Vingerhoets","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2009.12.058_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann. Neurol."}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811909013470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811909013470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T08:53:18Z","timestamp":1544777598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811909013470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1053811909013470"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroimage.2009.12.058","relation":{},"ISSN":["1053-8119"],"issn-type":[{"value":"1053-8119","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}